Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

Glenmark Pharmaceutical Ltd.'s shares rose over 5% during trade on Monday, after the management highlighted a 300.2% sales ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

This product, a generic equivalent of Atrovent nasal spray by Boehringer Ingelheim, will be manufactured at Lupin’s Pithampur facility in India. The nasal spray is indicated for treating ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

the new nasal spray dosage form mandates the use of a specific dispensing instrument. It also includes standards for formulation. The Ayurvedic Pharmacopoeia of India will continue to define ...

DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...

Glenmark Pharma Chairman discusses US tariffs, upcoming launches, and diabetes portfolio expansion, highlighting benefits for drugmakers.